The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Patel Sanj K

Reporting owner CIK 0001532218 · CHAIRMAN & CEO · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Patel Sanj KPatel Sanj KPatel Sanj K · November 13, 2025 · Gift received · Class A Ordinary SharePatel Sanj K · November 12, 2025 · Gift received · Class A Ordinary SharePatel Sanj K · October 22, 2025 · Exercise / conversion · Class A Ordinary SharePatel Sanj K · October 21, 2025 · Exercise / conversion · Class A Ordinary SharePatel Sanj K · October 20, 2025 · Exercise / conversion · Class A Ordinary ShareOct 20, 2025Nov 13, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 13, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePatel Sanj KGift received
Nov 12, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePatel Sanj KGift received
Oct 22, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePatel Sanj KExercise / conversion
Oct 21, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePatel Sanj KExercise / conversion
Oct 20, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary SharePatel Sanj KExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Patel Sanj KCHAIRMAN & CEO · Director
Gift receivedClass A Ordinary ShareNon-derivative security · Code G60,0000Value: 0Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Patel Sanj KCHAIRMAN & CEO · Director
Gift receivedClass A Ordinary ShareNon-derivative security · Code G111,7940Value: 0Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Patel Sanj KCHAIRMAN & CEO · Director
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M97,3903.8Value: 370,082Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Patel Sanj KCHAIRMAN & CEO · Director
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M39,3313.8Value: 149,457.8Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Patel Sanj KCHAIRMAN & CEO · Director
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M121,2483.8Value: 460,742.4Currency not specifiedView ↗